18 virus-"https:"-"https:"-"https:"-"https:"-"https:"-"https:"-"https:"-"https:"-"https:" positions at Amsterdam UMC
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
In this Postdoc position, you will investigate bone remodelling and fracture healing in a rare genetic bone disorder, Osteogenesis Imperfecta (OI), using a human-relevant organ-on-chip model. OI is
-
of the blood-brain barrier disrupts the glymphatic system. This may accelerate the aggregation of amyloid beta in and around blood vessels, a condition known as cerebral amyloid angiopathy (CAA). Would you like
-
POLARIS doctoral network POLARIS is a European Marie Skłodowska-Curie Doctoral Network focused on accelerating therapy development for leukodystrophies: rare genetic disorders affecting the brain's
-
POLARIS doctoral network POLARIS is a European Marie Skłodowska-Curie Doctoral Network focused on accelerating therapy development for leukodystrophies: rare genetic disorders affecting the brain's
-
of ongoing research projects, with ample room for your own initiatives. Amsterdam UMC offers a position within an enthusiastic team where you can contribute to cutting-edge research in vascular medicine. You
-
POLARIS doctoral network POLARIS is a European Marie Skłodowska-Curie Doctoral Network focused on accelerating therapy development for leukodystrophies: rare genetic disorders affecting the brain's
-
POLARIS doctoral network POLARIS is a European Marie Skłodowska-Curie Doctoral Network focused on accelerating therapy development for leukodystrophies: rare genetic disorders affecting the brain's
-
The POLARIS training network POLARIS is a European Marie Skłodowska-Curie Doctoral Network focused on accelerating therapy development for leukodystrophies: rare genetic disorders affecting
-
POLARIS doctoral network POLARIS is a European Marie Skłodowska-Curie Doctoral Network focused on accelerating therapy development for leukodystrophies: rare genetic disorders affecting the brain’s
-
by targeting the RNA splicing machinery, a promising therapeutic strategy for cancers with a high unmet medical need. In this project, which runs until the end of 2028, you will contribute